TREATMENT OF HEPARIN‐INDUCED THROMBOCYTOPENIA BY USE OF ARGATROBAN, A SYNTHETIC THROMBIN INHIBITOR
- 1 November 1992
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 82 (3), 627-629
- https://doi.org/10.1111/j.1365-2141.1992.tb06482.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Anticoagulant therapy with MD805 of a hemodialysis patient with heparin-induced thrombocytopeniaThrombosis Research, 1990
- Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysisThrombosis Research, 1988
- Plasma antithrombin activity of MD 805 determined by chromogenic substrate during hemodialysis.Blood & Vessel, 1987
- Heparin-Associated Thrombocytopenia Treatment with Low Molecular Weight HeparinThrombosis and Haemostasis, 1986
- Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acidBiochemistry, 1984